Join to View Full Profile
1000 FivepointIrvine, CA 92618
Phone+1 888-333-4673
Dr. Borogovac is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Azra Borogovac, MD, is a hematology specialist with a subspecialty in hematologic oncology, based in Irvine, CA. She completed her medical education at the University of Massachusetts Medical School in 2015, followed by a residency in internal medicine and a fellowship in hematology and medical oncology. Dr. Borogovac is currently an Assistant Clinical Professor at City of Hope Orange County, having previously held a position as Assistant Professor at OU Health. Her research has been published in various journals, including works on CAR T-cell therapy and immunotherapy in hematologic conditions. Some of her publications have been cited by other professionals in the field.
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
UMass Chan Medical SchoolResidency, Internal Medicine, 2015 - 2018- University of Massachusetts Medical SchoolClass of 2015
Certifications & Licensure
CA State Medical License 2022 - 2026
OK State Medical License 2017 - 2022
MA State Medical License 2017 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice.Neel S Bhatt, Azra Borogovac, Yvonne A Efebera, Anna DeSalvo, Steven M Devine
Blood Advances. 2025-09-09 - GPRC5D Bispecific antibody talquetamab-induced dizziness-ataxia syndrome, clinical presentation and management- a case series.Murali Janakiram, Lawrence Liu, Scott Goldsmith, Azra Borogovac, Sarah Lee
Blood Cancer Journal. 2025-08-11 - Real-world infectious complications of CD3/CD20 bispecific antibodies in relapsed/refractory non-Hodgkin lymphoma.Annie Xiao, Lu Chen, Stacy Pak, Brian Lee, Matthew Mei
Leukemia & Lymphoma. 2025-08-05
Press Mentions
How to Build a Successful Outpatient CAR T Cell Therapy ProgramApril 30th, 2025- What Is Leukemia? Symptoms, Causes and TreatmentJune 23rd, 2023
- Cancer Is Now Leading Cause of Death Among HIV-Positive People, Report Says: ‘Of Great Concern’January 24th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
